⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 6, 2015Cardiovascular DiabetologyOpen Access

Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes

Sanjoy K. Paul Kerenaftali Klein Brian Larsen Thorsted Michael Lyng Wolden Kamlesh Khunti

View Full Paper

Ask AI

Bookmark

Share

Abstract

Among patients with newly diagnosed T2DM, 22% remained under poor glycaemic control over 2 years, and 26% never received IT. Delay in IT by 1 year in conjunction with poor glycaemic control significantly increased the risk of MI, HF, stroke and composite CVE.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Paul et al. (2015) studied this question.

synapsesocial.com/papers/69d9ae941ad561c673684f8e https://doi.org/10.1186/s12933-015-0260-x

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Paget's Disease of the MandibleOriginal Research · 2008 · 610 citations
210-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes2008 · 7,749 citations
3Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyOriginal Research · 2008 · 3,832 citations
4Personalized Management of Hyperglycemia in Type 2 DiabetesHuman Clinical Trial · 2013 · 143 citations
5Clinical Inertia during Postoperative Management of Diabetes Mellitus: Relationship between Hyperglycemia and Insulin Therapy IntensificationRetrospective Study · 2013 · 31 citations

Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care2013
Clinical Inertia in People With Type 2 Diabetes2013
Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study2013
Revisiting the BMI-based obesity paradox in mortality risk across the cardiovascular-kidney-metabolic syndrome continuumCardiovascular Diabetology · 2026
Head-to-head comparison of six cumulative metabolic indices and joint association with renal function for incident cardiometabolic multimorbidity in non-diabetic adults with CKM syndrome stages 0–3: a prospective cohort studyCardiovascular Diabetology · 2026

More from Cardiovascular Diabetology

More from University of Leicester

More from QIMR Berghofer Medical Research Institute

More from Novo Nordisk (Denmark)